MyFinsight
Home
Blog
About
Contact
Download
Download image
Biopharmaceutical And Other
Biopharmaceutical Revenue
$301K
Testing
$135,091K
Product
$3,679K
Biopharmaceutical And Other
$301K
Total revenue
$139,071K
(21.49%↑ Y/Y)
Gross profit
$101,159K
(27.23%↑ Y/Y)
Total cost of revenue
$37,912K
(8.43%↑ Y/Y)
Income from operations
$22,646K
(679.82%↑ Y/Y)
Other income, net
$7,328K
(61.98%↑ Y/Y)
Total operating
expenses
$78,513K
(2.49%↑ Y/Y)
Cost of
revenue-Testing
$33,306K
Intangible asset
amortization - cost of revenue
$2,707K
(4.72%↑ Y/Y)
Cost of
revenue-Product
$1,891K
Cost of
revenue-Biopharmaceutical And Other
$8K
Income before income
taxes
$29,974K
(303.53%↑ Y/Y)
Selling and marketing
$27,156K
(11.05%↑ Y/Y)
Research and development
$27,098K
(52.92%↑ Y/Y)
General and
administrative
$23,680K
(-29.96%↓ Y/Y)
Intangible asset
amortization - operating...
$579K
(-6.91%↓ Y/Y)
Net income
$28,707K
(307.36%↑ Y/Y)
Income tax provision
$1,267K
(232.55%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
VERACYTE, INC. (VCYT)
VERACYTE, INC. (VCYT)